Original language | English (US) |
---|---|
Pages (from-to) | E1-E4 |
Journal | JAMA internal medicine |
Volume | 180 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2020 |
ASJC Scopus subject areas
- Internal Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Trends in e-Cigarette Use in Adults in the United States, 2016-2018. / Obisesan, Olufunmilayo H.; Osei, Albert D.; Uddin, S. M.Iftekhar; Dzaye, Omar; Mirbolouk, Mohammadhassan; Stokes, Andrew; Blaha, Michael J.
In: JAMA internal medicine, Vol. 180, No. 10, 01.10.2020, p. E1-E4.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Trends in e-Cigarette Use in Adults in the United States, 2016-2018
AU - Obisesan, Olufunmilayo H.
AU - Osei, Albert D.
AU - Uddin, S. M.Iftekhar
AU - Dzaye, Omar
AU - Mirbolouk, Mohammadhassan
AU - Stokes, Andrew
AU - Blaha, Michael J.
N1 - Funding Information: Corresponding Author: Michael J. Blaha, MD, MPH, Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, 600 N Wolfe St, Blalock 524D1 JHH, Baltimore, MD 21287 (mblaha1@jhmi.edu). Published Online: September 8, 2020. doi:10.1001/jamainternmed.2020.2817 Author Contributions: Dr Obisesan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Obisesan, Osei, Uddin, Dzaye, Mirbolouk, Blaha. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Obisesan, Osei, Uddin, Dzaye, Mirbolouk. Critical revision of the manuscript for important intellectual content: Obisesan, Osei, Uddin, Dzaye, Stokes, Blaha. Statistical analysis: All authors. Obtained funding: Dzaye, Blaha. Administrative, technical, or material support: Osei, Blaha. Supervision: Uddin, Dzaye, Mirbolouk, Blaha. Conflict of Interest Disclosures: Dr Uddin reported grants from the National Institutes of Health outside the submitted work. Dr Stokes reported grants from Johnson & Johnson Inc outside the submitted work. Dr Blaha reported grants from the US Food and Drug Administration and the American Heart Association during the conduct of the study; grants from the National Institutes of Health and Aetna Foundation, grants and personal fees from Amgen Foundation, and personal fees from Sanofi, Regneron, Novartis, Novo Nordisk, Bayer, Akcea, Zogenix, Tricida, and Gilead outside the submitted work. No other disclosures were reported. Funding/Support: This research was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the US Food and Drug Administration Center for Tobacco Products under awards P50HL120163 and U54HL120163.
PY - 2020/10/1
Y1 - 2020/10/1
UR - http://www.scopus.com/inward/record.url?scp=85090959260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090959260&partnerID=8YFLogxK
U2 - 10.1001/jamainternmed.2020.2817
DO - 10.1001/jamainternmed.2020.2817
M3 - Letter
C2 - 32897288
AN - SCOPUS:85090959260
VL - 180
SP - E1-E4
JO - JAMA Internal Medicine
JF - JAMA Internal Medicine
SN - 2168-6106
IS - 10
ER -